Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation


Atrial fibrillation is the most common heart disease in the world, with around 35 million patients in 2020. Here we reported the generation of IBMS-iPSC-015-06, IBMS-iPSC-016-06, and IBMS-iPSC-017-02 as human induced pluripotent stem cell (iPSC) lines from patients' peripheral blood mononuclear cells (PBMCs) with atrial fibrillation. The cell lines expressed properties of pluripotent stem cells, including pluripotent markers and the ability to differentiate into three germ layers. These cell lines served as suitable models for studying alternative therapies of atrial fibrillation. Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Authors Chiu YT, Tsai MH, Chan DZ, Ko HW, Lu HE, Huang CF, Lin YJ, Chang SL, Lo LW, Huang CY, Hu YF, Hsieh PCH, Chen SA
Journal Stem cell research
Publication Date 2021 Jul;54:102419
PubMed 34119955
DOI 10.1016/j.scr.2021.102419

Research Projects

Cell Lines